PulseTrendingJournal ClubResearchersJournalsExplore
Instagram
HomeTrendingJournal ClubExplore
Synapse
⌘+K
Synapse
October 5, 2025Neuro-OncologyOpen Access

P18.08.b Identification of Novel Therapeutic Options for the Treatment of Glioblastoma Using a High-Throughput Live-Imaging-Based Drug Screening Platform

View Full Paper
Ask AI
Bookmark
Share

Authors

MBManon BouzereauMFMarta V. FreitasJKJens M. Kelm

Discussion

Loading...

Member takes

Overview

This study reveals effective therapies for newly diagnosed glioblastoma, highlighting personalized treatment strategies.

Key Points

  • At least one treatment showed higher efficacy than standard-of-care agents like temozolomide and lomustine.
  • A combination of BRAF/MEK inhibitors demonstrated strong activity across multiple patient-derived glioblastoma microtumors.
  • Substantial inter-individual variability in drug response was noted, suggesting personalized approaches are vital.
  • The study utilized a novel high-throughput platform for testing patient-derived mini-tumors against a panel of clinically relevant drugs.

Cite This Study

Bouzereau et al. (2025) studied this question.

synapsesocial.com/papers/68e24e6fd6d66a53c2473bc6https://doi.org/10.1093/neuonc/noaf193.572
View Full Paper
Ask AI
Bookmark
Share